Recursion Pharmaceuticals Inc.

NASDAQ: RXRX
Share price (1/7/26): $4.86
Market cap (1/7/26): $2.526 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Prospectus with selling stockholder info

Prospectus with selling stockholder info

Prospectus with selling stockholder info

Prospectus with selling stockholder info

Registration of securities for employees

Ownership Filter

Gibson Christopher

News Filter

Positive Phase 1b/2 Results From Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

Other Events, Financial Statements or Exhibits

Reports Third Quarter 2025 Financial Results and Provides Business Update

Unregistered Sales of Equity Securities, Other Events, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Proxy related to merger

Other Filter

Scanned paper annual report submission

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Scanned paper annual report submission